and the mixture was stirred for 12 h at room temperature. The
mixture was then added to an ice/water mixture (150 mL) and
1 mL of acetic acid, and stirred for 15 min. The finely divided
precipitate was filtered and washed with water and cold methanol
until colorless, furnishing pure 5a (640 mg, 58%) as a bright
orange powder. dH (300 MHz, CDCl3–CF3COOD): 3.17 (s, 3H),
3.24 (s, 3H), 7.48–7.51 (m, 3H), 8.21–8.23 (m, 2H), 8.97 (s, 1H);
dC (75 MHz, CDCl3–CF3COOD): 16.5, 28.6, 108.2, 113.0, 116.8,
127.0, 127.7, 129.8, 132.7, 141.3, 160.4, 162.4; LR-MS (CI): 273
MH+; UV (CH2Cl2): kmax (log emax) = 476 nm (4.292), 450 nm
(4.213); mp 284 ◦C.
CDCl3); 15.5, 27.62, 55.04, 107.4, 109.2, 114.6, 120.3, 129.7, 142.5,
149.0, 159.8, 161.5, 162.0; MS (EI, 70 eV) m/z 302 (M+, 100),
287 (19), 269 (19), 256 (11), 255 (56). HRMS (EI+): calcd for
C15H14O3N2S (M+) 302.0725; found 302.0722. UV (CH2Cl2): kmax
(log emax) = 480 nm (4.331), 451 nm (4.243); mp 280 ◦C.
2-Allyl-5-methyl-6-(methylsulfanyl)-3-(2-thienyl)-1,4-(2H,5H)-
dioxopyrrolo[3,4-c]pyrrole (5g). Prepared following the general
procedure, starting from 4c (Ar = 2-thienyl, R = allyl), in 31%
yield after purification by column chromatography. dH (300 MHz,
CDCl3) 3.13 (s, 3H), 3.20 (s, 3H), 4.59 (t, 2H, J = 1.8 Hz), 5.11–
5.22 (m, 2H), 5.90–6.01 (m, 1H), 7.19 (t, 1H, J = 4.5 Hz), 7.55 (d,
1H, J = 6.4 Hz), 8.54 (m, 2H); dC (75 MHz, CDCl3) 16.2, 27.9,
44.1, 107.6, 108.4, 116.7, 128.5, 129.6, 130.5, 133.1, 133.9, 137.9,
152.6, 160.5, 160.7; LR-MS (CI): 319 MH+; UV (CH2Cl2): kmax
(log emax) = 492 nm (4.321), 308 nm (4.188); mp 143 ◦C.
2,6-Diphenyl-3-(methylsulfanyl)-1,4-(2H,5H)-dioxopyrrolo[3,4-
c]pyrrole (5b). Prepared in the same way from phenyl
isothiocyanate and 4a in 66% yield. dH (300 MHz, CDCl3)
3.09 (s, 3H), 7.31–7.36 (m, 3H), 7.46–7.53 (m, 5H), 8.19–8.23 (m,
2H), 8.48 (s, 1H); dC (75 MHz, CDCl3) 16.6, 109.4, 111.5, 128.5,
128.6, 129.6, 130.0, 130.2, 132.6, 135.2, 143.7, 151.8, 160.5, 162.8;
LR-MS (CI): 335 MH+; UV (CH2Cl2): kmax (log emax) = 472 nm
(4.485), 444 nm (4.327); mp 283–285 ◦C.
General procedure for compounds 9
tert-Butyl-2-(6-(methylsulfanyl)-1,4-dioxo-3,5-diphenyl-4,5-di-
hydropyrrolo[3,4-c]pyrrol-2(1H)-yl)acetate (9b). A suspension of
5b (100 mg, 0.30 mmol), K2CO3 (103 mg, 0.75 mmol) and NaI
(100 mg) in DMF (20 mL) was heated for 15 min until 5b was
dissolved. At room temperature tert-butyl bromoacetate (98 mg,
73 mL, 0.50 mmol) was added in a drop-wise manner. The reaction
mixture was stirred for 12 h at 80 ◦C. After cooling to room
temperature, the mixture was diluted with ethyl acetate (50 mL)
and water (50 mL). The organic phase was washed with water
(2 × 50 mL) and the aqueous phase was extracted with ethyl
acetate (3 × 40 mL). The combined organic phases were dried
over MgSO4. The solvent was evaporated under reduced pressure
and the residue was purified by column chromatography (silica gel,
CH2Cl2–ethyl acetate), furnishing 9b (46 mg, 34%) as an orange-
red powder. dH (300 MHz, CDCl3): 1.39 (s, 9H), 3.08 (s, 3H), 4.41
(s, 2H), 7.28–7.31 (m, 2H), 7.42–7.49 (m, 6H), 7.70–7.72 (m, 2H);
dC (75 MHz, CDCl3): 16.6, 28.3, 44.7, 83.0, 128.1, 128.7, 129.0,
129.3, 129.4, 129.6, 131.2, 134.4, 144.3, 155.1, 160.8, 161.8, 168.1;
UV (CH2Cl2): kmax (log emax) = 455 nm (4.159), 288 nm (4.006);
LR-MS (CI): 449 MH+; mp 127 ◦C.
2,6-Diphenyl-3-(benzylsulfanyl)-1,4-(2H,5H)-dioxopyrrolo[3,4-
c]pyrrole (5c). Prepared in the same way, using benzyl bromide
instead of methyl iodide, from phenyl isothiocyanate and 4a in
54% yield. dH (300 MHz, CDCl3) 5.00 (s, 2H), 7.25–7.31 (m, 7H),
7.44–7.56 (m, 6H), 8.43 (m, 2H), 11.32 (s, 1H); dC (75 MHz,
CDCl3) 65.7, 86.0, 125.7, 127.7, 127.8, 128.1, 128.2, 128.3, 129.4,
129.5, 129.8, 130.3, 135.1, 135.7, 144.1, 169.9, 173.8, 208.7;
LR-MS (CI): 411 MH+; UV (CH2Cl2): kmax (log emax) = 475 nm
(4.347), 448 nm (4.267); mp 264 ◦C.
2-(4-(N,N-Dimethylamino)phenyl)-6-phenyl-3-(methylsulfanyl)-
1,4-(2H,5H)-dioxopyrrolo[3,4-c]pyrrole (5d). Prepared in the
same way, from the corresponding isothiocyanate and 4a in
37% yield. dH(300 MHz, CDCl3) 2.52 (s, 6H), 2.93 (s, 3H), 6.82
(d, 2H, J = 8.8 Hz), 7.10 (d, 2H, J = 9.5 Hz), 7.49–7.53 (m,
3H), 8.28–8.32 (m, 2H), 11.16 (s, 1H); dC (75 MHz, CDCl3) a
sufficiently high concentration could not be reached; MS (EI,
70 eV) m/z 378 (MH+, 32), 377 (M+, 100), 331 (14), 330 (74),
302 (18), 134 (17); HRMS (EI+): calcd for C21H19O2N3S (M+)
377.11980; found 377.12029; UV (CH2Cl2): kmax (log emax) =
474 nm (4.45), 449 nm (4.262); mp >300 ◦C.
tert-Butyl-2-(3-phenyl-5-methyl-6-(methylsulfanyl)-1,4-dioxo-4,
5-dihydropyrrolo[3,4-c]pyrrol-2(1H)-yl)acetate (9a). Prepared
from 5a according to the general procedure in 86% yield, dH
(300 MHz, CDCl3): 1.38 (s, 9H), 3.15 (s, 3H), 3.17 (s, 3H), 4.34 (s,
2H), 7.46–7.53 (m, 3H), 7.65–7.70 (m, 2H); dC (75 MHz, CDCl3):
16.31, 27.9, 29.4, 44.5, 82.5, 107.3, 110.7, 128.3, 128.7, 129.0,
143.9, 155.1, 161.1, 161.3, 168.1, 169.9; UV (CH2Cl2): kmax (log
emax) = 456 nm (4.153), 287 nm (4.120); LR-MS (CI): 386 MH+;
mp 79 ◦C.
2-(4-(N,N-Dimethylamino)phenyl)-5-methyl-6-phenyl-3-(methyl-
sulfanyl)-1,4-(2H,5H)-dioxopyrrolo[3,4-c]pyrrole (5e). Prepared
following the general procedure, from the corresponding
isothiocyanate and 4d (Ar = Ph, R = Me), in 60% yield. dH
(300 MHz, CDCl3) 2.90 (s, 6H), 3.04 (s, 3H), 3.36 (s, 3H), 6.75
(d, 2H, J = 8.9 Hz), 7.13 (d, 2H, J = 9.1 Hz), 7.43–7.49 (m,
3H), 7.79–7.82 (m, 2H), 11.12 (s, 1H); dC (75 MHz, CDCl3) 16.4,
30.0, 40.7, 108.5, 109.6, 112.4, 122.7, 128.3, 129.1, 129.3, 131.0,
144.5, 151.0, 156.0, 156.1, 161.3, 162; MS (EI, 70 eV) m/z 391
(M+, 100), 345 (19), 344 (95), 172 (11): calcd for C22H21O2N3S
(M+) 391.13545; found 391.13545; UV (CH2Cl2): kmax (log emax) =
464 nm (4.277), 441 nm (4.219); mp 229 ◦C.
tert-Butyl-2-(3-(4-methoxyphenyl)-5-methyl-6-(methylsulfanyl)-
1,4-dioxo-4,5-dihydropyrrolo[3,4-c]pyrrol-2(1H)-yl)acetate (9c).
Prepared from 5f according to the general procedure in 70%
yield, dH (300 MHz, CDCl3): 1.39 (s, 9H), 3.13 (s, 3H), 3.16 (s,
3H), 3.80 (s, 3H), 4.34 (s, 2H), 6.95 (d, 2H, J = 8.8 Hz), 7.57
(d, 2H, J = 8.8 Hz); dC (75 MHz, CDCl3): 16.2, 28.8, 44.6, 55.7,
82.7, 109.8, 114.7, 120.5, 130.6, 144.2, 153.5, 161.1, 161.8, 168.1;
UV (CH2Cl2): kmax (log emax) = 462 nm (4.308), 298 nm (4.145);
LR-MS (CI): 417 MH+; mp 123 ◦C.
6-(4-Methoxyphenyl)-2-methyl-3-methylsulfanyl-1,4-(2H,5H)-
dioxopyrrolo[3,4-c]pyrrole (5f). Prepared following the general
procedure, starting from 4b (Ar = 4-anisyl, R = H), in 62% yield.
dH (300 MHz, CDCl3) 3.06 (s, 3H), 3.07 (s, 3H), 4.14 (s, 3H), 6.86 (d,
2H, J = 9.2 Hz), 7.57 (d, 2H, J = 9.1 Hz), 9.00 (s, 1H); dC (75 MHz,
2590 | Org. Biomol. Chem., 2007, 5, 2587–2591
This journal is
The Royal Society of Chemistry 2007
©